scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026673109 |
P356 | DOI | 10.1186/1752-1947-2-373 |
P932 | PMC publication ID | 2628933 |
P698 | PubMed publication ID | 19061488 |
P5875 | ResearchGate publication ID | 23628555 |
P50 | author | Jean-Marc Rolain | Q34572450 |
Fadi Bittar | Q49360813 | ||
Jean-Christophe Dubus | Q114779819 | ||
Nathalie Stremler | Q114779820 | ||
Jacques Sarles | Q114779821 | ||
Didier Raoult | Q915676 | ||
P2093 | author name string | Magalie Menuet | |
P2860 | cites work | 16S ribosomal DNA amplification for phylogenetic study | Q24681548 |
Infective endocarditis and septic embolization with Ochrobactrum anthropi: case report and review of literature | Q33977684 | ||
Brevundimonas bacteremia: two case reports and literature review. | Q35682343 | ||
Prosthetic mitral valve endocarditis due to Ochrobactrum anthropi: case report. | Q35717473 | ||
Pelvic abscess due to Ochrobactrum intermedium [corrected] in an immunocompetent host: case report and review of the literature | Q36414308 | ||
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. | Q40010382 | ||
Brevundimonas diminuta infections and its resistance to fluoroquinolones | Q40508937 | ||
Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis | Q41819863 | ||
Inquilinus limosus and cystic fibrosis | Q43230341 | ||
Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp. | Q46699027 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | cystic fibrosis | Q178194 |
emerging pathogen | Q108429945 | ||
P304 | page(s) | 373 | |
P577 | publication date | 2008-12-05 | |
P1433 | published in | Journal of Medical Case Reports | Q6295519 |
P1476 | title | First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report | |
P478 | volume | 2 |
Q83774556 | Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010 |
Q36720179 | Bacterial Evasion of Host Antimicrobial Peptide Defenses |
Q38026594 | Bacterial resistance to cationic antimicrobial peptides |
Q55023482 | Brevundimonas spp: Emerging global opportunistic pathogens. |
Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
Q33705998 | Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients |
Q57498708 | Evaluation of Exposure to and during Showering |
Q38211644 | Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings |
Q36171333 | First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate |
Q92302843 | History, Chemistry and Antibacterial Spectrum |
Q95322433 | Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection |
Q35124580 | Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy. |
Q39022860 | Neoagarotetraose protects mice against intense exercise-induced fatigue damage by modulating gut microbial composition and function |
Q41684286 | Pandoraea pulmonicola chronic colonization in a cystic fibrosis patient, France |
Q92302901 | Rational Combinations of Polymyxins with Other Antibiotics |
Q35861377 | The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy |
Q40476518 | Translocation and dissemination of commensal bacteria in post-stroke infection. |
Q35076797 | Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France |
Search more.